Changes in Membrane Cholesterol Differentially Influence Preferential and Non-preferential Signaling of the M1 and M3 Muscarinic Acetylcholine Receptors
Open Access
- 13 May 2014
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 40 (10) , 2068-2077
Abstract
We have found earlier that changes in membrane cholesterol content have distinct impact on signaling via the M1, M2, or M3 receptors expressed in CHO cells (CHO-M1 through CHO-M3). Now we investigated whether gradual changes in membrane cholesterol exerts differential effects on coupling of the M1 and M3 muscarinic receptors to preferential signaling pathways through Gq/11 and non-preferential Gs G-proteins signaling. Changes in membrane cholesterol resulted in only marginal alterations of antagonist and agonist affinity of the M1 and M3 receptors, and did not influence precoupling of either subtype. Changes in membrane cholesterol did not influence parameters of carbachol-stimulated GTP-γ35S binding in CHO-M1 membranes while reduction as well as augmentation of membrane cholesterol lowered the efficacy but increased the potency of carbachol in CHO-M3 membranes. Gradual increase or decrease in membrane cholesterol concentration dependently attenuated agonist-induced inositolphosphates release while only cholesterol depletion increased basal values in both cell lines. Similarly, membrane cholesterol manipulation modified basal and agonist-stimulated cAMP synthesis via Gs in the same way in both cell lines. These results demonstrate that changes in membrane cholesterol concentration differentially impact preferential and non-preferential M1 and M3 receptor signaling. They point to the activated G-protein/effector protein interaction as the main site of action in alterations of M1 receptor-mediated stimulation of second messenger pathways. On the other hand, modifications in agonist-stimulated GTP-γ35S binding in CHO-M3 membranes indicate that in this case changes in ligand-activated receptor/G-protein interaction may also play a role.Keywords
This publication has 39 references indexed in Scilit:
- Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer diseaseJournal of Experimental Medicine, 2012
- Subtype Differences in Pre-Coupling of Muscarinic Acetylcholine ReceptorsPLOS ONE, 2011
- Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacyBritish Journal of Pharmacology, 2010
- Structural basis of G protein–coupled receptor–G protein interactionsNature Chemical Biology, 2010
- Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathwaysEuropean Journal of Pharmacology, 2009
- Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid raftsJournal of Cell Biology, 2003
- Dual effects of muscarinic M2 acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonistsBritish Journal of Pharmacology, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Muscarinic acetylcholine receptors: Structural basis of ligand binding and G protein couplingLife Sciences, 1995
- Muscarinic receptor subtypes: Modulation of ion channelsLife Sciences, 1993